第一单位：
Translational Medicine, Oncology R&D, AstraZeneca, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge, CB2 0AA, UK. alan.barnicle@astrazeneca.com.
作者：
Alan,Barnicle [1]
;
Isabelle,Ray-Coquard [2]
;
Etienne,Rouleau [3]
;
Karen,Cadoo [4]
;
Fiona,Simpkins [5]
;
Carol,Aghajanian [4]
;
Alexandra,Leary [6]
;
Andrés,Poveda [7]
;
Stephanie,Lheureux [8]
;
Eric,Pujade-Lauraine [9]
;
Benoit,You [10]
;
Jonathan,Ledermann [11]
;
Ursula,Matulonis [12]
;
Charlie,Gourley [13]
;
Kirsten M,Timms [14]
;
Zhongwu,Lai [15]
;
Darren R,Hodgson [15]
;
Cathy E,Elks [16]
;
Simon,Dearden [16]
;
Coumaran,Egile [16]
;
Pierre,Lao-Sirieix [16]
;
Elizabeth A,Harrington [17]
;
Jessica S,Brown [17]
作者单位：
Translational Medicine, Oncology R&D, AstraZeneca, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge, CB2 0AA, UK. alan.barnicle@astrazeneca.com.
[1]
Medical Oncology Department, Centre Léon Bérard and University Claude Bernard Lyon, and Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Lyon, France.
[2]
Department of Medical Biology and Pathology, Gustave Roussy, Cancer Genetics Laboratory, Gustave Roussy, Villejuif, France.
[3]
Memorial Sloan Kettering Cancer Center, New York, NY, USA.
[4]
Department of Obstetrics and Gynecology, Jordan Center for Gynecologic Oncology at the Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
[5]
Institut Gustave Roussy, and GINECO, Villejuif, France.
[6]
Initia Oncology, Hospital Quironsalud, Valencia, Spain.
[7]
Department of Medical Oncology, Princess Margaret Hospital, Toronto, ONT, Canada.
[8]
Association de Recherche Cancers Gynécologiques (ARCAGY)-GINECO, and GINECO, Paris, France.
[9]
Medical Oncology, IC-HCL, EPSILYON, Univ Lyon 1, and GINECO, Lyon, France.
[10]
UCL Cancer Institute, University College London and UCL Hospitals, London, UK.
[11]
Dana-Farber Cancer Institute, Boston, MA, USA.
[12]
Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh, UK.
[13]
Myriad Genetics, Salt Lake City, UT, USA.
[14]
Translational Medicine, Oncology R&D, Research and Early Development, AstraZeneca, Boston, MA, USA.
[15]
Precision Medicine and Biosamples, Oncology R&D, AstraZeneca, Cambridge, UK.
[16]
Translational Medicine, Oncology R&D, AstraZeneca, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge, CB2 0AA, UK.
[17]
DOI
10.1186/s13073-024-01413-5
PMID
39695768
发布时间
2025-02-25
换一批
